Analyses performed on peripheral and tumor-resident ILCs from patients with solid cancers, including melanoma, detected variable levels of CTLA-4 expression on all ILC subsets, with tissue cells showing higher expression compared to that in the blood counterpart [24,40]. Here, CTLA4 is linked to melanoma.